IL10 and influenza: In a pre-clinical model using human PBMC to test different adjuvants combined with split-virus influenza vaccines (SVV), we have shown that addition of toll-like receptor (TLR) agonists can be used to improve the IFNγ:IL-10 ratios as well as GrB responses to influenza challenge [19].